'%20stroke-width='15'%20stroke-linecap='round'%20stroke-dasharray='0%2044%200%2044%200%2044%200%2044%200%20360'%20cx='100'%20cy='100'%20r='70'%20transform-origin='center'%3e%3canimateTransform%20type='rotate'%20attributeName='transform'%20calcMode='discrete'%20dur='2'%20values='360;324;288;252;216;180;144;108;72;36'%20repeatCount='indefinite'%3e%3c/animateTransform%3e%3c/circle%3e%3c/svg%3e%20--%3e%3csvg%20width='78'%20height='78'%20viewBox='0%200%2078%2078'%20fill='none'%20xmlns='http://www.w3.org/2000/svg'%3e%3crect%20x='14'%20y='17'%20width='48'%20height='44'%20fill='white'%20/%3e%3cpath%20d='M24.0741%2034.9365C21.432%2034.9365%2019.377%2037.0503%2019.377%2039.7365C19.377%2042.4228%2021.4466%2044.5512%2024.0741%2044.5512C26.7016%2044.5512%2028.7714%2042.4375%2028.7714%2039.7365C28.7714%2037.0356%2026.7016%2034.9365%2024.0741%2034.9365Z'%20fill='%235082AF'%20/%3e%3cpath%20d='M38.5614%200C17.2624%200%200%2017.2624%200%2038.5616C0%2059.8606%2017.2624%2077.123%2038.5614%2077.123C59.8606%2077.123%2077.123%2059.8606%2077.123%2038.5616C77.123%2017.2624%2059.8606%200%2038.5614%200ZM32.1469%2047.5597H28.7707V46.0624L28.6533%2046.1651C27.2734%2047.2661%2025.644%2047.8386%2023.8093%2047.8386C19.3469%2047.8386%2015.9853%2044.3597%2015.9853%2039.7506C15.9853%2035.1413%2019.3469%2031.6624%2023.8093%2031.6624C25.5853%2031.6624%2027.2734%2032.2349%2028.6533%2033.3358L28.7707%2033.4238V31.9267H32.1469V47.5597ZM43.0238%2044.5506C44.7707%2044.5506%2046.3413%2043.611%2047.1486%2042.0992H50.7891C49.7616%2045.5781%2046.723%2047.824%2043.0238%2047.824C38.4147%2047.824%2034.9358%2044.345%2034.9358%2039.7358C34.9358%2035.1267%2038.4147%2031.6477%2043.0238%2031.6477C46.7083%2031.6477%2049.7469%2033.8936%2050.7891%2037.3872H47.1634C46.356%2035.8459%2044.8147%2034.9211%2043.0093%2034.9211C40.367%2034.9211%2038.312%2037.0349%2038.312%2039.7358C38.312%2042.4368%2040.3818%2044.5506%2043.0093%2044.5506H43.0238ZM60.213%2035.2H56.9835V42.7157C56.9835%2043.5963%2057.6882%2044.2862%2058.5835%2044.2862H60.213V47.5597H58.5835C55.7506%2047.5597%2053.6074%2045.4754%2053.6074%2042.7157V29.2992H56.9835V31.9267H60.213V35.2Z'%20fill='%235082AF'%20/%3e%3c/svg%3e)
'%3e%3cg%20clip-path='url(%23clip1_1328_800)'%3e%3crect%20width='22'%20height='16'%20rx='2'%20fill='%23F93939'/%3e%3cpath%20fill-rule='evenodd'%20clip-rule='evenodd'%20d='M0%2011H23V16H0V11Z'%20fill='%23FFDA2C'/%3e%3cpath%20fill-rule='evenodd'%20clip-rule='evenodd'%20d='M0%200H23V5H0V0Z'%20fill='%23151515'/%3e%3c/g%3e%3c/g%3e%3cdefs%3e%3cclipPath%20id='clip0_1328_800'%3e%3crect%20width='22'%20height='16'%20fill='white'/%3e%3c/clipPath%3e%3cclipPath%20id='clip1_1328_800'%3e%3crect%20width='22'%20height='16'%20rx='2'%20fill='white'/%3e%3c/clipPath%3e%3c/defs%3e%3c/svg%3e)
Die GlycoEra Ltd, ein Schweizer Biotechnologieunternehmen, das extrazelluläre Protein-Degrader zur Behandlung von Autoimmunerkrankungen entwickelt, hat eine Series-B-Finanzierung über USD 130 Millionen abgeschlossen. Die überzeichnete Runde wurde von Novo Holdings angeführt, mit Beteiligung der neuen Investoren LifeArc Ventures, Catalio Capital Management, QIA, MP Healthcare Venture Management, Sixty Degree Capital und Agent Capital. Auch bestehende Investoren beteiligten sich, darunter Sofinnova Partners, 5AM Ventures, Roche Ventures und Bristol Myers Squibb.
Max Klement (Partner, Novo Holdings), Matthew Hobson (Principal, Catalio Capital Management) und Sohaib Mir (Partner, LifeArc Ventures) treten in den Verwaltungsrat von GlycoEra ein.
act legal Switzerland (vormals BGPartner AG) beriet den Lead-Investor Novo Holdings und den neuen Investor LifeArc Ventures in sämtlichen Fragen des Schweizer Rechts sowie bei den Verhandlungen dieser Series-B-Finanzierung. Das Team bestand aus Oliver Gnehm, Victoria Marty, Tessa Douma und Anja Spahni.
